As we also show in this study that anti-VEGF treatment of triple negative breast cancer cells completely suppresses AngII-induced migration, our results may also indicate the potency of a new strategy, using a combined treatment of Ang-(1-7) and anti- VEGF to prevent invasion, angiogenesis, and metastasis of aggressive breast cancer tumors. The gene discussed is VEGFA; the disease is breast carcinoma.